The HNRNPK gene helps cells manage RNA, the working copies of genetic instructions, and supports normal growth and development. When this gene is not working properly, the body may have trouble coordinating early development, and some people have Au-Kline syndrome. This can involve developmental delay, low muscle tone, feeding difficulties, and differences in the face, heart, kidneys, or genital development. It is mostly discussed in medical genetics rather than everyday media.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Other genes mainly help control when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medicines. If you want to look into this subject more closely, you can learn more in the LearnHub.
Overview
HNRNPKGene function
What if the gene works
The HNRNPK gene helps cells control how genetic instructions are read and turned into working proteins. It supports normal growth, brain development, and other routine cell activities.
Risk
What if the gene does not work
Variants in the HNRNPK gene can cause Au-Kline syndrome, which often affects development, learning, speech, and muscle tone. Some people also have differences in growth, appearance, or the heart, kidneys, or skeleton. Effects can range from milder to more severe.
Treatment
What does that mean for your treatment
If you carry a pathogenic variant in the HNRNPK gene, no treatment or drug approach guided by this gene is currently established in clinical guidelines. Care is based on the person’s symptoms, and the HNRNPK gene is also being studied in cancer as a possible biomarker and treatment target.
Conditions associated with HNRNPK
Gene function
What if the gene works
In everyday cell life, the HNRNPK gene helps manage how genetic instructions are used. Its protein can bind both DNA and RNA, which lets it guide several steps between a gene and a working protein. This supports steady cell activity across many tissues.
The HNRNPK gene helps cells decide when certain genes should be read and used. By attaching near active genes, its protein supports orderly timing of cell instructions.
After a gene is read, the HNRNPK gene helps shape the RNA message before it is used. This includes guiding splicing, a normal editing step that joins the useful pieces together.
Its protein helps keep RNA messages stable and in the right place inside the cell. This supports smooth movement from the nucleus to the cell's protein making areas.
The HNRNPK gene also helps control when some RNA messages are turned into proteins. This is part of how the HNRNPK gene helps cells make proteins at the right time.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the HNRNPK gene reduce the amount or activity of hnRNP K, a protein that helps cells manage RNA and control other genes. In understanding how variants in the HNRNPK gene affect protein function, milder missense variants may partly weaken binding to RNA, DNA, or partner proteins, while more severe loss-of-function variants often leave cells with too little working protein. This range in effect can influence how strongly cell signaling and gene control are disrupted.
How variants are linked to conditions
Pathogenic variants in the HNRNPK gene cause Au-Kline syndrome, a rare developmental condition. In studies of the HNRNPK gene variants and Au-Kline syndrome, affected people may have developmental delay, speech and learning challenges, low muscle tone, and differences in growth or organ development. When a clearly pathogenic HNRNPK variant is found in someone with matching features, it can confirm the diagnosis.
A variant is not necessarily a diagnosis
Variants in genes are common and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a part. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the HNRNPK gene. In most reported cases, the main factor is having a disease-causing change in the gene itself, rather than lifestyle or environmental exposures.
Inheritance of HNRNPK variants
For families asking how HNRNPK gene variants are inherited, the main established pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the HNRNPK gene can pass it to each child with a 50% chance in each pregnancy, regardless of sex. Many known cases happen because of a new, de novo variant, meaning the change was not inherited from either parent. If a parent carries the variant, it can be passed from mother or father to sons or daughters.
What does my HNRNPK result mean for my family?
A disease-causing result in the HNRNPK gene is usually linked to a dominant condition, so close relatives such as parents, brothers, sisters, and children may also carry the same change and may want to discuss testing. For many families, the change happened new in the affected child, which means neither parent carries it. Even so, family implications depend on the exact result and the condition involved.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the HNRNPK gene, genetic testing for HNRNPK variants examines DNA from blood, saliva, or a cheek swab. A lab reads the gene’s sequence and compares it with the usual version to identify changes that may help explain a known or suspected genetic condition.
When should I consider getting a genetic test?
Genetic testing for the HNRNPK gene may be considered when a child has unexplained developmental delay, learning problems, low muscle tone, feeding or growth problems, or birth differences affecting organs such as the heart or kidneys. It can help confirm a condition called Au-Kline syndrome when these features occur together.
A genetic result is only one part of your health story
Genetic results can be helpful, but what they reveal varies with the condition and with the kind of variant found. Over time, the way the body functions is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help put individual experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how quickly a drug is broken down, how strongly it works, or how likely side effects are. This helps explain why the same treatment may work well for one person, seem less effective for another, or feel too strong at a usual dose.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way medications work. It studies gene-drug patterns to clarify why the same treatment can have different effects from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the HNRNPK gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so general medication concerns are best discussed with your doctor. HNRNPK has been explored in cancer research as a possible factor in how some tumor cells respond to treatment, but this is not used in routine prescribing.
History
HNRNPK entered medical genetics through basic laboratory research on a group of proteins that attach to RNA and were mapped in the late 20th century. From these first observations, research expanded steadily. By the 1990s and 2000s, studies showed that changes affecting HNRNPK were being seen in several cancers, which brought the gene broader attention in cancer biology. A major clinical milestone came in 2015, when harmful variants in the HNRNPK gene were identified as the cause of Au-Kline syndrome, linking years of laboratory work to a recognizable inherited condition. Since then, the gene’s history has reflected a common path in genetics: discovery in the lab first, followed by clearer meaning for patients and families.